Geneuro

4 email addresses found for geneuro.com
4 email addresses
http://agora-sep.org/t7-bientot-une-phase-iib August 8, 2017
http://businesswire.com/news/home/20141202005462/en/geneuro-servier-sign-partnership-develop-medicine-addressing October 10, 2017
http://coveram.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor December 12, 2016
http://coversyl.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor April 4, 2017
http://daflon500.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor April 4, 2017
http://daflon.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://diamicron.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://eclosionventures.com/geneuro-successful-completion-of-phase-i March 3, 2018
http://forseps.org/t1876p125-suivi-essai-geneve-et-bale August 8, 2017
http://forseps.org/t1975-articles October 10, 2017
http://forum.actudz.com/topic25581.html October 10, 2017
http://forum.actudz.com/topic25582.html October 10, 2017
http://geneuro.com/en/news/press_articles.php October 10, 2015
http://locabiotal.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://multiplesclerosis.elsevierresource.com/article/placebo-randomized-controlled-study-test-efficacy-and-safety-gnbac1-monoclonal-antibody November 11, 2017
http://natrilix.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://ncbi.nlm.nih.gov/pubmed/23200102 July 7, 2017
http://preterax.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://procoralan.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor December 12, 2016
http://protelos.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor April 4, 2017
http://servier.co.id/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor June 6, 2018
http://servier.com.cn/news/geneuro%E4%B8%8E%E6%96%BD%E7%BB%B4%E9%9B%85%E7%AD%BE%E7%BD%B2%E5%90%88%E4%BD%9C%E5%8D%8F%E8%AE%AE%EF%BC%8C%E5%85%B1%E5%90%8C%E7%A0%94%E5%8F%91%E6%B2%BB%E7%96%97%E5%A4%9A%E5%8F%91%E6%80%A7%E7%A1%AC%E5%8C%96%E7%97%85%E5%9B%A0%E7%9A%84%E9%A6%96%E4%BE%8B%E8%8D%AF%E7%89%A9 June 6, 2015
http://servier.com//content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor December 12, 2016
http://servier.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor June 6, 2015
http://stablon.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor April 4, 2017
http://stephreports.com/news/2012/12/page/9 March 3, 2017
http://thisisms.com/forum/drug-pipeline-f13/topic21380-15.html April 4, 2015
http://trivastal.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor April 4, 2017
http://valdoxan.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://vastarel.com/content/geneuro-and-servier-sign-partnership-develop-first-medicine-addressing-causal-factor March 3, 2017
http://coveram.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis December 12, 2016
http://coversyl.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis April 4, 2017
http://daflon500.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis April 4, 2017
http://daflon.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://diamicron.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://geneuro.ch/en/investors/documentation-2/press-releases-doc October 10, 2016
http://geneuro.ch/en/investors/financial-agenda/coming-financial-events October 10, 2016
http://geneuro.ch/en/investors/geneuro-in-brief October 10, 2016
http://geneuro.ch/en/investors/geneuro-share/share-id October 10, 2016
http://geneuro.ch/en/investors/welcome October 10, 2016
http://geneuro.com/en/investors/documentation-2/press-releases-doc November 11, 2016
http://geneuro.com/en/investors/financial-agenda/coming-financial-events November 11, 2016
http://geneuro.com/en/investors/geneuro-in-brief November 11, 2016
http://geneuro.com/en/investors/geneuro-share/share-id November 11, 2016
http://geneuro.com/en/investors/welcome November 11, 2016
http://itespresso.fr/press-release/geneuro-annonce-le-traitement-des-premiers-patients-de-son-tude-de-phase-iib-dans-la-sclrose-en-plaques May 5, 2017
http://itespresso.fr/press-release/geneuro-bilan-semestriel-du-contrat-de-liquidit-contract-avec-la-socit-de-bourse-gilbert-dupont May 5, 2017
http://itespresso.fr/press-release/geneuro-intgre-les-indices-cac-mid-small-cac-small-et-cac-all-tradable-deuronext March 3, 2017
http://life-sciences-germany.com/news/geneuro-signs-crada-agreement-euronext-paris-gnro-institut-2001-109882.html March 3, 2017
http://locabiotal.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://natrilix.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://preterax.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://procoralan.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis December 12, 2016
http://protelos.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis April 4, 2017
http://servier.com//content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis December 12, 2016
http://servier.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis December 12, 2016
http://stablon.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis April 4, 2017
http://trivastal.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis April 4, 2017
http://valdoxan.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017
http://vastarel.com/content/geneuro-and-servier-announce-angel-ms-extension-clinical-study-multiple-sclerosis March 3, 2017

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about geneuro.com

Language of the website: English